黑色素:在癌症治疗中是一个天然的守护者
Yurou Cao1, Hang Zhang1, Xubin Chen2
1School of Stomatology, Hainan Medical University and Hainan Academy of Medical Sciences, Haikou, Hainan, China.
Frontiers in pharmacology
|August 4, 2025
概括
黑激素 (MLT) 是一种天然的激素,通过抑制瘤生长和增强药物疗效,显示出强大的抗癌特性. 尽管存在诸如低生物可用性等局限性,但向性输送为癌症治疗提供了未来的潜力.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 黑色素 (MLT),腺激素,具有显著的抗癌特性.
- MLT表现出抗氧化,抗增殖,抗血管新生和亲的功能.
- 它的抗癌机制包括表观遗传调节,代谢重编程,免疫调节和PI3K/AKT通路信号传递.
研究的目的:
- 审查黑激素的抗癌作用.
- 探索黑色素抗瘤活性背后的机制.
- 讨论黑激素在联合癌症治疗中的潜力和未来的临床应用.
主要方法:
- 关于黑色素抗癌作用的临床前和临床研究的文献综述.
- 对调查黑激素作用机制的研究进行分析.
- 评估涉及黑色素和常规抗癌药物的组合治疗研究.
主要成果:
- 黑素表现出广泛的抗癌活性,包括抑制瘤细胞的增殖,迁移和血管生成,同时诱导亡.
- 关键机制包括表观遗传修饰,代谢重编程,免疫微环境调节和PI3K/AKT通路的调节.
- 黑色素显著增强了化疗剂的疗效,如西斯,5-甲和帕克利塔塞尔.
- 诸如低生物利用率和快速新陈代谢等挑战限制了临床使用,但正在通过向治疗和个性化治疗来解决这些挑战.
结论:
- 黑色素是一种有前途的天然化合物,具有多方面的抗癌作用.
- 结合治疗和黑可以提高各种癌症的治疗结果.
- 通过先进的输送系统克服药物动力学限制对于实现黑激素在瘤学中的全部治疗潜力至关重要.
相关概念视频
Management of Insomnia
322
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
322
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


